Most recently, it's been determined that conolidine and the above derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar parts as classical opioid receptors, it binds to some big range of endogenous opioids. Contrary to most opioid receptors, this receptor functions as a scavenger and isn't going to activate